Filing Details ORAMED PHARMACEUTICALS INC. (NASDAQ:ORMP) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on August 03, 2026. The…
ORAMED PHARMACEUTICALS INC. (NASDAQ:ORMP) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on August 03, 2026.
The Healthcare company's proxy statement provides information for shareholders ahead of the annual meeting, including board nominations, executive compensation, and proposals for shareholder vote.
ORAMED PHARMACEUTICALS INC.'s stock currently trades at $4.39 with a market capitalization of $126.5M.
SEC filings provide mandatory disclosures that give investors access to the same material information available to institutional investors. Reviewing ORAMED PHARMACEUTICALS INC.'s filings alongside price action and analyst commentary provides a more complete picture of the company's current situation.
All SEC filings for ORAMED PHARMACEUTICALS INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ORMP Stock Page
Browse all filings on our ORMP SEC filings page.
Public companies like ORAMED PHARMACEUTICALS INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Current market data
NASDAQ · ORMP
$5.02
Up: +$0.07 · +1.39%
Live quote updated
Keep reading
